Breschi, Gian Luca, Federica Demma, Paolo Morelli, and Maria De Francesco. “Brentuximab Vedotin in Adult Patients With HL CD30+ at High Risk of Relapse or Progression Following ASCT: A Cost-Analysis in Italy”. AboutOpen 8, no. 1 (September 2, 2021): 81–87. Accessed April 25, 2024. https://journals.aboutscience.eu/index.php/aboutopen/article/view/2263.